{"count": 2, "results": [{"_id": "35366264", "pmid": 35366264, "pmcid": "PMC8830455", "title": "The Angiotensin-Converting Enzyme Inhibitor Lisinopril Mitigates Memory and Motor Deficits in a Drosophila Model of Alzheimer's Disease", "journal": "Pathophysiology", "authors": ["Thomas J", "Smith H", "Smith CA", "Coward L", "Gorman G", "De Luca M", "Jumbo-Lucioni P"], "date": "2021-06-18T00:00:00Z", "doi": "10.3390/pathophysiology28020020", "meta_date_publication": "2021 Jun 18", "meta_volume": "28", "meta_issue": "2", "meta_pages": "307-319", "score": 50295.96, "text_hl": "The @GENE_ANCE @GENE_34805 @@@Angiotensin-Converting Enzyme@@@ Inhibitor @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ Mitigates @DISEASE_Memory_Disorders @DISEASE_MESH:D008569 @@@Memory@@@ and @<m>DISEASE_Neurologic_Manifestations</m> @DISEASE_MESH:D009461 @@@Motor Deficits@@@ in a @SPECIES_7227 @@@Drosophila@@@ Model of @DISEASE_Alzheimer_Disease @DISEASE_MESH:D000544 @@@Alzheimer's Disease@@@", "citations": {"NLM": "Thomas J, Smith H, Smith CA, Coward L, Gorman G, De Luca M, Jumbo-Lucioni P. The Angiotensin-Converting Enzyme Inhibitor Lisinopril Mitigates Memory and Motor Deficits in a Drosophila Model of Alzheimer's Disease Pathophysiology. 2021 Jun 18;28(2):307-319. PMID: 35366264", "BibTeX": "@article{35366264, title={The Angiotensin-Converting Enzyme Inhibitor Lisinopril Mitigates Memory and Motor Deficits in a Drosophila Model of Alzheimer's Disease}, author={Thomas J and Smith H and Smith CA and Coward L and Gorman G and De Luca M and Jumbo-Lucioni P}, journal={Pathophysiology}, volume={28}, number={2}, pages={307-319}}"}}, {"_id": "11334854", "pmid": 11334854, "title": "Neurovascular interactions between aldose reductase and angiotensin-converting enzyme inhibition in diabetic rats.", "journal": "Eur J Pharmacol", "authors": ["Cotter MA", "Mirrlees DJ", "Cameron NE"], "date": "2001-04-13T00:00:00Z", "doi": "10.1016/s0014-2999(01)00909-8", "meta_date_publication": "2001 Apr 13", "meta_volume": "417", "meta_issue": "3", "meta_pages": "223-30", "score": 50047.02, "text_hl": "After 8 weeks of @CHEMICAL_Streptozocin @CHEMICAL_MESH:D013311 @@@streptozotocin@@@-induced @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@, sciatic nerve blood flow and motor conduction velocity were 51% and 21% reduced, respectively. Two weeks of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ treatment dose-dependently corrected the @<m>DISEASE_Neurologic_Manifestations</m> @DISEASE_MESH:D009461 @@@conduction deficit@@@ (ED(50) approximately 0.9 mg kg(-1)). ", "citations": {"NLM": "Cotter MA, Mirrlees DJ, Cameron NE. Neurovascular interactions between aldose reductase and angiotensin-converting enzyme inhibition in diabetic rats. Eur J Pharmacol. 2001 Apr 13;417(3):223-30. PMID: 11334854", "BibTeX": "@article{11334854, title={Neurovascular interactions between aldose reductase and angiotensin-converting enzyme inhibition in diabetic rats.}, author={Cotter MA and Mirrlees DJ and Cameron NE}, journal={Eur J Pharmacol}, volume={417}, number={3}, pages={223-30}}"}}]}